Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol.
Armstrong
Stephen C
SC
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000037:antagonists & inhibitors* / Q000633:toxicity; D000975:Antioxidants / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis; D002227:Carbazoles / Q000494:pharmacology* / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000378:metabolism / Q000517:prevention & control; D000077261:Carvedilol; D004317:Doxorubicin / Q000037:antagonists & inhibitors* / Q000633:toxicity; D004789:Enzyme Activation; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism; D011412:Propanolamines / Q000494:pharmacology* / Q000627:therapeutic use; D011494:Protein Kinases / Q000502:physiology
D000903:Antibiotics, Antineoplastic; D000975:Antioxidants; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D004317:Doxorubicin; D011494:Protein Kinases